APA (7th ed.) Citation

D, A., J, B., I, S., P, V., D, L., J, T., . . . F, H. (2026). Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 51(8), 1511. https://doi.org/10.1038/s41386-026-02428-9

Chicago Style (17th ed.) Citation

D, Arikci, et al. "Acute Dose-dependent Effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) Compared with 3,4-methylenedioxymethamphetamine (MDMA) and Psilocybin in a Double-blind, Placebo-controlled Study in Healthy Participants." Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology 51, no. 8 (2026): 1511. https://doi.org/10.1038/s41386-026-02428-9.

MLA (9th ed.) Citation

D, Arikci, et al. "Acute Dose-dependent Effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) Compared with 3,4-methylenedioxymethamphetamine (MDMA) and Psilocybin in a Double-blind, Placebo-controlled Study in Healthy Participants." Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, vol. 51, no. 8, 2026, p. 1511, https://doi.org/10.1038/s41386-026-02428-9.